Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treatment Of Children And Adolescents With Hodgkin's Disease
NCT00025064Phase 2Unknown
- Sponsor
- Children's Cancer and Leukaemia Group
- Start
- Jan 2000
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands, Covalent Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of chlorambucil, vinblastine, prednisolone, procarbazine, doxorubicin in Hodgkin lymphoma (HL), sponsored by Children's Cancer and Leukaemia Group. Status: unknown.
02
Drugs
chlorambucilvinblastineprednisoloneprocarbazinedoxorubicin
03
Conditions
Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on NCT00025064.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00025064.